Cathy Burgess, a Health Care Group partner in the firm’s Washington, D.C. office, was prominently featured in an FDA Enforcement Manual article discussing the need for compliance measures to assure drug supplier quality.
The full article sharing Burgess’ insights can be viewed here.
The full article sharing Burgess’ insights can be viewed here.